<DOC>
	<DOCNO>NCT01237301</DOCNO>
	<brief_summary>The purpose study evaluate use SMBG CGM clinical decision related management type 2 diabetes . The secondary objective determine benefit use CGM clinical diabetes management decision-making .</brief_summary>
	<brief_title>Comparing Self Monitored Blood Glucose ( SMBG ) Continuous Glucose Monitoring ( CGM ) Type 2 Diabetes</brief_title>
	<detailed_description>This study involve use follow 2 glucose monitoring method measure blood sugar ( glucose ) level help manage type 2 diabetes : 1 . Self Monitoring Blood Glucose ( SMBG ) : blood glucose measure 4-7 time day use finger stick AccuChek Aviva blood glucose meter . 2 . Continuous Glucose Monitoring ( CGM ) : blood glucose measure continuously via DexCom SevenPlus CGM device . This device approve use U.S. Food Drug Administration ( FDA ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Male female ≥18 ≤75 year age ( Upper range assure dexterity use CGM ) Clinical diagnosis type 2 diabetes HbA1c ≥7.0 % Diabetes treat follow therapy within one month prior study enrollment : ( 1 ) medical nutrition therapy alone metformin ; ( 2 ) sulfonylurea without metformin ; ( 3 ) DPP4 inhibitor GLP1 agonist without metformin ; insulin without metformin . Treated TZD Administered prednisone cortisone medication previous 30 day Currently pregnant plan pregnancy study period Presence severe medical psychological condition chronic conditions/infections opinion Investigator would compromise subject 's safety successful participation study HbA1c &lt; 7.0 % Unable follow study protocol Unable speak , read write English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Continuous Glucose Monitoring</keyword>
</DOC>